These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28035989)

  • 61. Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.
    Li S; Yeo KS; Levee TM; Howe CJ; Her ZP; Zhu S
    Cells; 2021 Mar; 10(3):. PubMed ID: 33800887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
    Tomolonis JA; Agarwal S; Shohet JM
    Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroblastoma: paradigm for precision medicine.
    Irwin MS; Park JR
    Pediatr Clin North Am; 2015 Feb; 62(1):225-56. PubMed ID: 25435121
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patient-derived xenografts as preclinical neuroblastoma models.
    Braekeveldt N; Bexell D
    Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.
    Middelbeek J; Visser D; Henneman L; Kamermans A; Kuipers AJ; Hoogerbrugge PM; Jalink K; van Leeuwen FN
    Oncotarget; 2015 Apr; 6(11):8760-76. PubMed ID: 25797249
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
    Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
    Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroblastoma and dendritic cell function.
    Redlinger RE; Mailliard RB; Barksdale EM
    Semin Pediatr Surg; 2004 Feb; 13(1):61-71. PubMed ID: 14765372
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
    Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
    J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
    Schmelz K; Toedling J; Huska M; Cwikla MC; Kruetzfeldt LM; Proba J; Ambros PF; Ambros IM; Boral S; Lodrini M; Chen CY; Burkert M; Guergen D; Szymansky A; Astrahantseff K; Kuenkele A; Haase K; Fischer M; Deubzer HE; Hertwig F; Hundsdoerfer P; Henssen AG; Schwarz RF; Schulte JH; Eggert A
    Nat Commun; 2021 Nov; 12(1):6804. PubMed ID: 34815394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent insights into the biology of neuroblastoma.
    Schleiermacher G; Janoueix-Lerosey I; Delattre O
    Int J Cancer; 2014 Nov; 135(10):2249-61. PubMed ID: 25124476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.
    Das S; Bryan K; Buckley PG; Piskareva O; Bray IM; Foley N; Ryan J; Lynch J; Creevey L; Fay J; Prenter S; Koster J; van Sluis P; Versteeg R; Eggert A; Schulte JH; Schramm A; Mestdagh P; Vandesompele J; Speleman F; Stallings RL
    Oncogene; 2013 Jun; 32(24):2927-36. PubMed ID: 22797059
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.
    Hsu CL; Chang HY; Chang JY; Hsu WM; Huang HC; Juan HF
    Oncotarget; 2016 Jun; 7(24):36293-36310. PubMed ID: 27167114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Robust pathway-based multi-omics data integration using directed random walks for survival prediction in multiple cancer studies.
    Kim SY; Jeong HH; Kim J; Moon JH; Sohn KA
    Biol Direct; 2019 Apr; 14(1):8. PubMed ID: 31036036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular and genetic bases of neuroblastoma.
    Kamijo T; Nakagawara A
    Int J Clin Oncol; 2012 Jun; 17(3):190-5. PubMed ID: 22588778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advances in the diagnosis and treatment of neuroblastoma.
    Weinstein JL; Katzenstein HM; Cohn SL
    Oncologist; 2003; 8(3):278-92. PubMed ID: 12773750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Top advances of the year: Pediatric oncology.
    Pappo AS; Karol SE; Bertrand KC
    Cancer; 2022 Oct; 128(20):3593-3596. PubMed ID: 36074012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics.
    van Gerven MR; Bozsaky E; Matser YAH; Vosseberg J; Taschner-Mandl S; Koster J; Tytgat GAM; Molenaar JJ; van den Boogaard M
    Cancer Sci; 2022 Jun; 113(6):2167-2178. PubMed ID: 35384159
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel framework for horizontal and vertical data integration in cancer studies with application to survival time prediction models.
    Mihaylov I; Kańduła M; Krachunov M; Vassilev D
    Biol Direct; 2019 Nov; 14(1):22. PubMed ID: 31752974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.
    Nallasamy P; Chava S; Verma SS; Mishra S; Gorantla S; Coulter DW; Byrareddy SN; Batra SK; Gupta SC; Challagundla KB
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):53-65. PubMed ID: 29196189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.